The role of IL-33 in gut mucosal inflammation

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Pastorelli, Luca ^a,b,c   De Salvo, Carlo ^a,b,c   Vecchi, Maurizio ^b,c   GvPizarro, Theresa T ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; EOTAXIN 2; INFLIXIMAB; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE;

CROHN DISEASE; CYTOKINE PRODUCTION; DNA POLYMORPHISM; ENTERITIS; GENETIC SUSCEPTIBILITY; GOBLET CELL; HUMAN; MUCOSAL IMMUNITY; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; UPREGULATION; WOUND HEALING; ANIMAL; GASTROINTESTINAL TRACT; GENETICS; IMMUNOLOGY; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; METABOLISM;

ANIMALIA;

ANIMALS; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; INTESTINAL MUCOSA;

EID: 84878636647     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/608187     Document Type: Review

References (84)

1. Kaser A., Zeissig S., Blumberg R. S., Inflammatory bowel disease. Annual Review of Immunology 2010 28 573 621 2-s2.0-77952316009 10.1146/annurev-immunol- 030409-101225
2. Casini-Raggi V., Kam L., Chong Y. J. T., Fiocchi C., Pizarro T. T., Cominelli F., Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease: a novel mechanism of chronic intestinal inflammation. Journal of Immunology 1995 154 5 2434 2440 2-s2.0-0028898529
3. Cominelli F., Nast C. C., Duchini A., Lee M., Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992 103 1 65 71 2-s2.0-0026697049
4. Pizarro T. T., Michie M. H., Bentz M., Woraratanadharm J., Smith M. F., Foley E., Moskaluk C. A., Bickston S. J., Cominelli F., IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. Journal of Immunology 1999 162 11 6829 6835 2-s2.0-0033152023 (Pubitemid 29309411)
5. Monteleone G., Trapasso F., Parrello T., Biancone L., Stella A., Iuliano R., Luzza F., Fusco A., Pallone F., Bioactive IL-18 expression is up-regulated in Crohn's disease. Journal of Immunology 1999 163 1 143 147 2-s2.0-0033168120 (Pubitemid 29295835)
6. Kanai T., Watanabe M., Okazawa A., Sato T., Yamazaki M., Okamoto S., Ishii H., Totsuka T., Iiyama R., Okamoto R., Ikeda M., Kurimoto M., Takeda K., Akira S., Hibi T., Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 2001 121 4 875 888 2-s2.0-0034800289 (Pubitemid 32959397)
7. Dinarello C., Arend W., Sims J., IL-1 family nomenclature. Nature Immunology 2010 11 article 973 10.1038/ni1110-973
8. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T. K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D. M., Bazan J. F., Kastelein R. A., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005 23 5 479 490 2-s2.0-27744446058 10.1016/j.immuni.2005.09.015 (Pubitemid 41587888)
9. Baekkevold E. S., Roussigné M., Yamanaka T., Johansen F. E., Jahnsen F. L., Amalric F., Brandtzaeg P., Erard M., Haraldsen G., Girard J. P., Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. American Journal of Pathology 2003 163 1 69 79 2-s2.0-0037631696 (Pubitemid 36759592)
10. Cayrol C., Girard J. P., The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proceedings of the National Academy of Sciences of the United States of America 2009 106 22 9021 9026 2-s2.0-67049158193 10.1073/pnas.0812690106
11. Lüthi A. U., Cullen S. P., McNeela E. A., Duriez P. J., Afonina I. S., Sheridan C., Brumatti G., Taylor R. C., Kersse K., Vandenabeele P., Lavelle E. C., Martin S. J., Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009 31 1 84 98 2-s2.0-68249137289 10.1016/j.immuni.2009.05.007
12. Talabot-Ayer D., Lamacchia C., Gabay C., Palmer G., Interleukin-33 is biologically active independently of caspase-1 cleavage. Journal of Biological Chemistry 2009 284 29 19420 19426 2-s2.0-67651053209 10.1074/jbc.M901744200
13. Lefrancais E., Roga S., Gautier V., IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proceedings of the National Academy of Sciences of the United States of America 2012 109 1673 1678 10.1073/pnas.1115884109
14. Hong J., Bae S., Jhun H., Lee S., Choi J., Kang T., Kwak A., Hong K., Kim E., Jo S., Kim S., Identification of constitutively active interleukin 33 (IL-33) splice variant. Journal of Biological Chemistry 2011 286 22 20078 20086 2-s2.0-79957595391 10.1074/jbc.M111.219089
15. Fagundes C. T., Amaral F. A., Souza A. L. S., Vieira A. T., Xu D., Liew F. Y., Souza D. G., Teixeira M. M., ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. Journal of Leukocyte Biology 2007 81 2 492 499 2-s2.0-33846698559 10.1189/jlb.0606422 (Pubitemid 46198401)
16. Palmer G., Lipsky B. P., Smithgall M. D., Meininger D., Siu S., Talabot-Ayer D., Gabay C., Smith D. E., The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008 42 3 358 364 2-s2.0-44449104907 10.1016/j.cyto.2008.03.008
17. Bulek K., Swaidani S., Qin J., Lu Y., Gulen M. F., Herjan T., Min B., Kastelein R. A., Aronica M., Kosz-Vnenchak M., Li X., The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. Journal of Immunology 2009 182 5 2601 2609 2-s2.0-64849087206 10.4049/jimmunol.0802729
18. Humphreys N. E., Xu D., Hepworth M. R., Liew F. Y., Grencis R. K., IL-33, a potent inducer of adaptive immunity to intestinal nematodes. Journal of Immunology 2008 180 4 2443 2449 2-s2.0-42149179961
19. Neill D. R., Wong S. H., Bellosi A., Flynn R. J., Daly M., Langford T. K. A., Bucks C., Kane C. M., Fallon P. G., Pannell R., Jolin H. E., McKenzie A. N. J., Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010 464 7293 1367 1370 2-s2.0-77951817855 10.1038/nature08900
20. Kondo M., Tamaoki J., Takeyama K., Nakata J., Nagai A., Interleukin-13 induces goblet cell differentiation in primary cell culture from guinea pig tracheal epithelium. American Journal of Respiratory Cell and Molecular Biology 2002 27 5 536 541 2-s2.0-0036845165 (Pubitemid 35301807)
21. Kibe A., Inoue H., Fukuyama S., Machida K., Matsumoto K., Koto H., Ikegami T., Aizawa H., Hara N., Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. American Journal of Respiratory and Critical Care Medicine 2003 167 1 50 56 2-s2.0-0037215576 10.1164/rccm.2110084 (Pubitemid 36015917)
22. Jones L. A., Roberts F., Nickdel M. B., Brombacher F., McKenzie A. N. J., Henriquez F. L., Alexander J., Roberts C. W., IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. European Journal of Immunology 2010 40 2 426 436 2-s2.0-75149148187 10.1002/eji.200939705
23. Huang X., Du W., Barrett R. P., Hazlett L. D., ST2 is essential for Th2 responsiveness and resistance to Pseudomonas aeruginosa keratitis. Investigative Ophthalmology and Visual Science 2007 48 10 4626 4633 2-s2.0-35748951316 10.1167/iovs.07-0316 (Pubitemid 351260980)
24. Wagenaar J. F., Gasem M. H., Goris M. G. A., Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLOS Neglected Tropical Diseases 2009 3 article e453 10.1371/journal.pntd.0000453
25. Wong S. H., Walker J. A., Jolin H. E., Transcription factor RORalpha is critical for nuocyte development. Nature Immunology 2012 13 229 236 10.1038/ni.2208
26. Fallon P. G., Ballantyne S. J., Mangan N. E., Barlow J. L., Dasvarma A., Hewett D. R., McIlgorm A., Jolin H. E., McKenzie A. N. J., Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. Journal of Experimental Medicine 2006 203 4 1105 1116 2-s2.0-33645888708 10.1084/jem.20051615
27. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., Furusawa J. I., Ohtani M., Fujii H., Koyasu S., Innate production of TH2 cytokines by adipose tissue-associated c-Kit+ Sca-1+ lymphoid cells. Nature 2010 463 7280 540 544 2-s2.0-75749122181 10.1038/nature08636
28. Price A. E., Liang H. E., Sullivan B. M., Reinhardt R. L., Eisley C. J., Erle D. J., Locksley R. M., Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proceedings of the National Academy of Sciences of the United States of America 2010 107 25 11489 11494 2-s2.0-77954926597 10.1073/pnas.1003988107
29. Saenz S. A., Siracusa M. C., Perrigoue J. G., Spencer S. P., Urban J. F., Tocker J. E., Budelsky A. L., Kleinschek M. A., Kastelein R. A., Kambayashi T., Bhandoola A., Artis D., IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses. Nature 2010 464 7293 1362 1366 2-s2.0-77951817294 10.1038/nature08901
30. Kurokawa M., Matsukura S., Kawaguchi M., Ieki K., Suzuki S., Odaka M., Watanabe S., Homma T., Sato M., Yamaguchi M., Takeuchi H., Adachi M., Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. International Archives of Allergy and Immunology 2011 155 supplement 1 12 20 2-s2.0-79958111349 10.1159/000327259
31. Cominelli F., Pizarro T. T., Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 1996 10 supplement 2 49 54 2-s2.0-0029824730
32. Reuter B. K., Pizarro T. T., Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe? European Journal of Immunology 2004 34 9 2347 2355 2-s2.0-4644367878 10.1002/eji.200425351 (Pubitemid 39302792)
33. Beltrán C. J., Núñez L. E., Díaz- Jiménez D., Farfan N., Candia E., Heine C., López F., González M. J., Quera R., Hermoso M. A., Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2010 16 7 1097 1107 2-s2.0-77953721901 10.1002/ibd.21175
34. Kobori A., Yagi Y., Imaeda H., Ban H., Bamba S., Tsujikawa T., Saito Y., Fujiyama Y., Andoh A., Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. Journal of Gastroenterology 2010 45 10 999 1007 2-s2.0-78249249625 10.1007/s00535-010-0245-1
35. Pastorelli L., Garg R. R., Hoang S. B., Spina L., Mattioli B., Scarpa M., Fiocchi C., Vecchi M., Pizarro T. T., Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 17 8017 8022 2-s2.0-77952324145 10.1073/pnas.0912678107
36. Seidelin J. B., Bjerrum J. T., Coskun M., Widjaya B., Vainer B., Nielsen O. H., IL-33 is upregulated in colonocytes of ulcerative colitis. Immunology Letters 2010 128 1 80 85 2-s2.0-74649085973 10.1016/j.imlet.2009.11.001
37. Miller A. M., Xu D., Asquith D. L., IL-33 reduces the development of atherosclerosis. The Journal of Experimental Medicine 2008 205 2 339 346 10.1084/jem.20071868 (Pubitemid 351281600)
38. Wood I. S., Wang B., Trayhurn P., IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochemical and Biophysical Research Communications 2009 384 1 105 109 2-s2.0-65549163320 10.1016/j.bbrc.2009.04.081
39. Pizarro T. T., Pastorelli L., Bamias G., SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis. Inflammatory Bowel Diseases 2011 17 2566 2584 10.1002/ibd.21638
40. Rivera-nieves J., Bamias G., Vidrich A., Marini M., Pizarro T. T., McDuffie M. J., Moskaluk C. A., Cohn S. M., Cominelli F., Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Gastroenterology 2003 124 4 972 982 2-s2.0-0037379778 10.1053/gast.2003.50148 (Pubitemid 36389800)
41. Bamias G., Martin C., Mishina M., Ross W. G., Rivera-Nieves J., Marini M., Cominelli F., Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 2005 128 3 654 666 2-s2.0-15744391229 10.1053/j.gastro.2004.11.053 (Pubitemid 40585368)
42. Díaz-Jiménez D., Núñez L. E., Beltrán C. J., Candia E., Suazo C., Álvarez-Lobos M., González M. J., Hermoso M. A., Quera R., Soluble ST2: a new and promising activity marker in ulcerative colitis. World Journal of Gastroenterology 2011 17 17 2181 2190 2-s2.0-79955857793 10.3748/wjg.v17.i17.2181
43. Latiano A., Palmieri O., Pastorelli L., Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel sisease. PLoS One 2013 8 article e62144
44. Liu X., Li M., Wu Y., Zhou Y., Zeng L., Huang T., Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochemical and Biophysical Research Communications 2009 386 1 181 185 2-s2.0-67649207586 10.1016/j.bbrc.2009.06.008
45. Xu D., Jiang H. R., Kewin P., Li Y., Mu R., Fraser A. R., Pitman N., Kurowska-Stolarska M., McKenzie A. N. J., McInnes I. B., Liew F. Y., IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10913 10918 2-s2.0-49449111630 10.1073/pnas.0801898105
46. Palmer G., Talabot-Ayer D., Lamacchia C., Toy D., Seemayer C. A., Viatte S., Finckh A., Smith D. E., Gabay C., Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis and Rheumatism 2009 60 3 738 749 2-s2.0-61649117392 10.1002/art.24305
47. Komai-Koma M., Xu D., Li Y., McKenzie A. N. J., McInnes I. B., Liew F. Y., IL-33 is a chemoattractant for human Th2 cells. European Journal of Immunology 2007 37 10 2779 2786 2-s2.0-35348850153 10.1002/eji.200737547 (Pubitemid 47578297)
48. Ali S., Huber M., Kollewe C., Bischoff S. C., Falk W., Martin M. U., IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18660 18665 2-s2.0-36749067367 10.1073/pnas.0705939104 (Pubitemid 350210753)
49. Zhiguang X., Wei C., Steven R., Wei D., Wei Z., Rong M., Zhanguo L., Lianfeng Z., Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. Immunology Letters 2010 131 2 159 165 2-s2.0-77953728457 10.1016/j.imlet.2010.04.005
50. Takedatsu H., Mitsuyama K., Matsumoto S., Handa K., Suzuki A., Takedatsu H., Funabashi H., Okabe Y., Hara T., Toyonaga A., Sata M., Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice. European Journal of Immunology 2004 34 6 1561 1569 2-s2.0-3242717983 10.1002/eji.200324680 (Pubitemid 39256037)
51. Mitsuyama K., Matsumoto S., Rose-John S., Suzuki A., Hara T., Tomiyasu N., Handa K., Tsuruta O., Funabashi H., Scheller J., Toyonaga A., Sata M., STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Gut 2006 55 9 1263 1269 2-s2.0-33747774200 10.1136/gut.2005. 079343 (Pubitemid 44277357)
52. Zhang Z., Zheng M., Bindas J., Schwarzenberger P., Kolls J. K., Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflammatory Bowel Diseases 2006 12 5 382 388 2-s2.0-33646804892 10.1097/01.MIB.0000218764. 06959.91
53. Ahern P. P., Izcue A., Maloy K. J., Powrie F., The interleukin-23 axis in intestinal inflammation. Immunological Reviews 2008 226 1 147 159 2-s2.0-55149112367 10.1111/j.1600-065X.2008.00705.x
54. O'Connor W. Jr., Kamanaka M., Booth C. J., Town T., Nakae S., Iwakura Y., Kolls J. K., Flavell R. A., A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nature Immunology 2009 10 6 603 609 2-s2.0-65749091607 10.1038/ni.1736
55. Pastorelli L., Garg R. R., Mattioli B., Interleukin-17 producing CD11b+ population is selectively expanded by interleukin-33 in an experimental model of spontaneous intestinal inflammation. Gastroenterology 2011 140 S115 S116
56. Mattioli B., Pastorelli L., de Salvo C., IL-33-dependent induction of intestinal profibrotic gene expression and myofibroblast hypertrophy: potential role in inflammatory-associated gut fibrosis. Gastroenterology 2011 140 S844 S845
57. de Salvo C., Wang X.-M., Mattioli B., Tu1950 pathogenic role of IL-33-mediated eosinophil infiltration and function in experimental IBD. Gastroenterology 2012 142 article S885
58. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003 52 1 65 70 2-s2.0-0037216498 10.1136/gut.52.1.65 (Pubitemid 36020767)
59. Song C., Luo L., Lei Z., Li B., Liang Z., Liu G., Li D., Zhang G., Huang B., Feng Z. H., IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. Journal of Immunology 2008 181 9 6117 6124 2-s2.0-58749093940
60. Lopetuso L. R., Scaldaferri F., Pizarro T. T., Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis. Fibrogenesis & Tissue Repair 2012 5 article 18 10.1186/1755-1536-5-18
61. Oboki K., Ohno T., Kajiwara N., Arae K., Morita H., Ishii A., Nambu A., Abe T., Kiyonari H., Matsumoto K., Sudo K., Okumura K., Saito H., Nakae S., IL-33 is a crucial amplifier of innate rather than acquired immunity. Proceedings of the National Academy of Sciences of the United States of America 2010 107 43 18581 18586 2-s2.0-78649821588 10.1073/pnas.1003059107
62. Dieleman L. A., Ridwan B. U., Tennyson G. S., Beagley K. W., Bucy R. P., Elson C. O., Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994 107 6 1643 1652 2-s2.0-0028006855 (Pubitemid 24357616)
63. Imaeda H., Andoh A., Aomatsu T., Uchiyama K., Bamba S., Tsujikawa T., Naito Y., Fujiyama Y., Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis. International Journal of Molecular Medicine 2011 28 4 573 578 2-s2.0-79960752111 10.3892/ijmm.2011.718
64. Sedhom M. A., Pichery M., Murdoch J. R., Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut 2013 10.1136/gutjnl-2011-301785
65. Pushparaj P. N., Li D., Komai-Koma M., Interleukin-33 exacerbates acute colitis via Interleukin-4 in mice. Immunology 2013 10.1111/imm.12111
66. Sanada S., Hakuno D., Higgins L. J., Schreiter E. R., McKenzie A. N. J., Lee R. T., IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. Journal of Clinical Investigation 2007 117 6 1538 1549 2-s2.0-34249882513 10.1172/JCI30634 (Pubitemid 46871338)
67. Miller A. M., Asquith D. L., Hueber A. J., Anderson L. A., Holmes W. M., McKenzie A. N., Xu D., Sattar N., McInnes I. B., Liew F. Y., Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circulation Research 2010 107 5 650 658 2-s2.0-77957043879 10.1161/CIRCRESAHA.110.218867
68. Volarevic V., Mitrovic M., Milovanovic M., Protective role of IL-/ST2 axis in Con A-induced hepatitis. Journal of Hepatology 2012 56 1 26 33 10.1016/j.jhep.2011.03.022
69. Jiang H. R., Milovanović M., Allan D., IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages. European Journal of Immunology 2012 42 1804 1814 10.1002/eji.201141947
70. Ouziel R., Gustot T., Moreno C., The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice. The American Journal of Pathology 2012 180 160 2330 2339 10.1016/j.ajpath.2012.03.009
71. Alves-Filho J. C., Snego F., Souto F. O., Freitas A., Verri W. A., Auxiliadora-Martins M., Basile-Filho A., McKenzie A. N., Xu D., Cunha F. Q., Liew F. Y., Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nature Medicine 2010 16 6 708 712 2-s2.0-77953185426 10.1038/nm.2156
72. Anthony R. M., Kobayashi T., Wermeling F., Ravetch J. V., Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway. Nature 2011 475 7354 110 114 2-s2.0-79960046406 10.1038/nature10134
73. Gro β P., Doser K., Falk W., Obermeier F., Hofmann C., IL-33 attenuates development and perpetuation of chronic intestinal inflammation. Inflammatory Bowel Diseases 2012 18 1900 1909 10.1002/ibd.22900
74. Okamoto R., Tsuchiya K., Nemoto Y., Akiyama J., Nakamura T., Kanai T., Watanabe M., Requirement of notch activation during regeneration of the intestinal epithelia. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009 296 1 G23 G35 2-s2.0-58249123433 10.1152/ajpgi.90225.2008
75. Sponheim J., Pollheimer J., Olsen T., Balogh J., Hammarström C., Loos T., Kasprzycka M., Sørensen D. R., Nilsen H. R., Küchler A. M., Vatn M. H., Haraldsen G., Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. American Journal of Pathology 2010 177 6 2804 2815 2-s2.0-78650199530 10.2353/ajpath.2010.100378
76. Pastorelli L., de Salvo C., Garg R. R., Mo1779 interleukin-33 induces distinct gastric epithelial alterations and plays an important role in the pathogenesis of murine gastritis. Gastroenterology 2012 142 supplement 1, article S683
77. Küchler A. M., Pollheimer J., Balogh J., Sponheim J., Manley L., Sorensen D. R., De Angelis P. M., Scott H., Haraldsen G., Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. American Journal of Pathology 2008 173 4 1229 1242 2-s2.0-53149119525 10.2353/ajpath.2008.080014
78. Duan L., Chen J., Zhang H., Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3(+) regulatory T-cell responses in mice. Molecular Medicine 2012 18 753 761
79. Bianchi M. E., DAMPs, PAMPs and alarmins: all we need to know about danger. Journal of Leukocyte Biology 2007 81 1 1 5 2-s2.0-33845951211 10.1189/jlb.0306164 (Pubitemid 46028489)
80. Kakkar R., Hei H., Dobner S., Lee R. T., Interleukin 33 as a mechanically responsive cytokine secreted by living cells. The Journal of Biological Chemistry 2012 287 6941 6948 10.1074/jbc.M111.298703
81. Nile C. J., Barksby E., Jitprasertwong P., Preshaw P. M., Taylor J. J., Expression and regulation of interleukin-33 in human monocytes. Immunology 2010 130 2 172 180 2-s2.0-77952087293 10.1111/j.1365-2567.2009.03221.x
82. Hudson C. A., Christophi G. P., Gruber R. C., Wilmore J. R., Lawrence D. A., Massa P. T., Induction of IL-33 expression and activity in central nervous system glia. Journal of Leukocyte Biology 2008 84 3 631 643 2-s2.0-50849142256 10.1189/jlb.1207830
83. Besnard A. G., Guillou N., Tschopp J., Erard F., Couillin I., Iwakura Y., Quesniaux V., Ryffel B., Togbe D., NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy 2011 66 8 1047 1057 2-s2.0-79959963904 10.1111/j.1398-9995.2011.02586.x
84. Kouzaki H., Iijima K., Kobayashi T., O'Grady S. M., Kita H., The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. Journal of Immunology 2011 186 7 4375 4387 2-s2.0-79955040263 10.4049/jimmunol.1003020